Diagnostic performance of contrast-enhanced spectral mammography in the evaluation of suspicious microcalcifications without associated mass
- 6 October 2025
- journal article
- Published by SAGE Publications in Acta Radiologica
- Vol. 67 (1) , 34-42
Abstract
Background: Contrast-enhancing magnetic resonance imaging is an expensive examination compared to contrast-enhanced spectral mammography (CESM) and cannot show microcalcifications. Purpose: To investigate the diagnostic performance of CESM for malignancy with microcalcifications alone and the relationship between tumor immunohistochemistry findings and tumor grade. Material and Methods: A total of 117 patients with suspected microcalcification at CESM were applied to our hospital between January 2022 and May 2024. Patients with accompanying mass and architectural distortion (n = 9) and the ones lacking pathology results (n = 11) were excluded. Patients with CESM and histopathological diagnosis (n = 97) were evaluated retrospectively. Mammography images were analyzed according to the American College of Radiology Breast Imaging-Reporting and Data System lexicon. Results: In our study, the diagnostic value of the presence of contrast enhancement in CESM was high in the evaluation of suspicious breast microcalcifications. Malignant pathology was detected in all of the microcalcifications with high-risk morphology. In addition, all of the microcalcifications that enhanced in solid and ground-glass form were invasive ductal carcinoma. However, no significant relationship was found between immunohistochemical parameters (ER, PR, CerB2, Ki-67 and grade) and enhancement in CESM. The highest enhancement rate among malignant subtypes was detected in the luminal B group. Conclusion: CESM is useful to reduce the number of unnecessary benign biopsies with suspicious microcalcifications in the breast, and provides an important contribution to the radiologist's biopsy decision by simultaneously showing the morphological features of the microcalcification and the contrast enhancement information.Keywords
This publication has 28 references indexed in Scilit:
- Multivariable model to predict breast cancer in non-mass enhancement lesions: a study on contrast-enhanced mammographyEuropean Radiology, 2025
- Malignancy risk stratification prediction of BI-RADS 4B calcifications based on contrast-enhanced mammographic features: a multicenter studyBreast Cancer Research and Treatment, 2024
- Assessing the malignancy of suspicious breast microcalcifications: the role of contrast enhanced mammographyLa radiologia medica, 2024
- Contrast-Enhanced Spectral Mammography and tumor size assessment: a valuable tool for appropriate surgical management of breast lesionsLa radiologia medica, 2022
- Improving the Diagnostic Accuracy of Breast BI-RADS 4 Microcalcification-Only Lesions Using Contrast-Enhanced MammographyClinical Breast Cancer, 2021
- Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysisThe Breast, 2021
- The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter studyEuropean Radiology, 2020
- Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysisClinical Breast Cancer, 2018
- Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysisEuropean Radiology, 2015
- Microcalcifications Associated with Breast Cancer: An Epiphenomenon or Biologically Significant Feature of Selected Tumors?Journal of Mammary Gland Biology and Neoplasia, 2005